Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer

Bibliographic Details
Main Authors:	Cao, Guo-dong, Xu, Xing-yu, Zhang, Jia-wei, Chen, Bo, Xiong, Mao-ming
Format:	Online
Language:	English
Published:	Public Library of Science 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179011/

Similar Items

Brain size is controlled by the mammalian target of rapamycin (mTOR) in mice
by: Kim, Woo-Yang
Published: (2015)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
by: Gao, Wei, et al.
Published: (2012)

mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01)

Targeting glutaminase and mTOR
by: Tanaka, Kazuhiro, et al.
Published: (2015)

mTOR, autophagy, and reprogramming
by: Tang, Bor Luen
Published: (2014)

mTOR and lysosome regulation
by: Puertollano, Rosa
Published: (2014)

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis
by: Li, Shuangjiang, et al.
Published: (2016)

The Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
by: Soliman, Ghada A.
Published: (2013)

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
by: Seto, Belinda
Published: (2012)

The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
by: Hartman, Adam L., et al.
Published: (2012)

mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain
by: Yang, Haijuan, et al.
Published: (2013)

Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
by: Lin, Hugo You-Hsien, et al.
Published: (2014)

The Paradox of Akt-mTOR Interactions
by: Vadlakonda, Lakshmipathi, et al.
Published: (2013)

Where is mTOR and what is it doing there?
by: Betz, Charles, et al.
Published: (2013)

Biological Aspects of mTOR in Leukemia
by: Simone Mirabilii, et al.
Published: (2018-08-01)

mTOR inhibitors in cancer therapy
by: Xie, Jianling, et al.
Published: (2016)

Inhibitors of mTOR in aging and cancer
by: Zhavoronkov, Alexander
Published: (2015)

mTOR Signaling, Translational Control, and the Circadian Clock
by: Ruifeng Cao, et al.
Published: (2018-09-01)

Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy
by: Sha, Long-Ze, et al.
Published: (2012)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
by: Gipson, Tanjala T., et al.
Published: (2012)

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
by: Gamper, Christopher J., et al.
Published: (2012)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
by: Raychaudhuri, Smriti K, et al.
Published: (2014)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
by: Rodrik-Outmezguine, Vanessa S., et al.
Published: (2016)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
by: Renna, Maurizio
Published: (2016)

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors
by: Hassan, Burhan, et al.
Published: (2014)

Glutamate transporter-dependent mTOR phosphorylation in Müller glia cells
by: María López-Colomé, Ana, et al.
Published: (2012)

mTOR-dependent phosphorylation controls TFEB nuclear export
by: Gennaro Napolitano, et al.
Published: (2018-08-01)

The Prognostic Role of mTOR and P-mTOR for Survival in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Li, Lei, et al.
Published: (2015)

New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
by: Carraway, Hetty, et al.
Published: (2004)

Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumors
by: Piña, Y, et al.
Published: (2011)

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
by: Elfiky, Aymen A, et al.
Published: (2011)

Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells
by: Dai, Zhi-Jun, et al.
Published: (2013)

Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)
by: Nemes, Karolina, et al.
Published: (2013)

Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging
by: Leontieva, Olga V., et al.
Published: (2012)

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
by: Maniscalco, Lorella, et al.
Published: (2013)

The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)
by: Yaba, Aylin, et al.
Published: (2012)

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
by: Dufour, Marc, et al.
Published: (2011)

Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
by: Wang Xiaoping, et al.
Published: (2016-01-01)

Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade
by: Rivera Rivera, Amilcar, et al.
Published: (2016)

Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs)
by: Gharbi, Chems, et al.
Published: (2014)